Cargando…

Correlation between Serum Levels of High Mobility Group Box-1 Protein and Pancreatitis: A Meta-Analysis

Background. Aberrant expression of high mobility group box-1 protein (HMGB1) contributes to the progression of various inflammatory diseases. This meta-analysis focused on the clinical significance of serum HMGB1 levels in pancreatitis patients, with the goal of building a novel diagnostic score mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yan, Lin, Lian-Jie, Jin, Yu, Cao, Yong, Zhang, Ying, Zheng, Chang-Qing, Liu, Jia-Li, Yang, Sheng-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324490/ https://www.ncbi.nlm.nih.gov/pubmed/25695079 http://dx.doi.org/10.1155/2015/430185

Ejemplares similares

Retracted: Correlation between Serum Levels of High Mobility Group Box-1 Protein and Pancreatitis: A Meta-Analysis
por: BioMed Research International,
Publicado: (2019)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
por: Zhou, Yu, et al.
Publicado: (2010)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Increased of serum high-mobility group box chromosomal protein 1 correlated with intestinal mucosal barrier injury in patients with severe acute pancreatitis
por: Xu, Gui-fang, et al.
Publicado: (2014)

Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?
por: Inkaya, Ahmet Cagkan, et al.
Publicado: (2017)

Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis
por: Zhu, Bin, et al.
Publicado: (2018)

Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis
por: Zhu, Bin, et al.
Publicado: (2019)

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2012)

A cross‐sectional study of vitreous and serum high mobility group box‐1 levels in proliferative diabetic retinopathy
por: Shen, Yinchen, et al.
Publicado: (2019)

High mobility group box 1 levels as potential predictors of asthma severity
por: Xu, Shuanglan, et al.
Publicado: (2023)

Association between high-mobility group box 1 levels and febrile seizures in children: a systematic review and meta-analysis
por: Li, Shangbin, et al.
Publicado: (2023)

Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis
por: Wang, Haipeng, et al.
Publicado: (2015)

High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation
por: Xu, Qiwen, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

Mortality at 180‐days is affected by serum haptoglobin levels in septic patients with high magnitude serum high mobility group box‐1 levels
por: Mizuno, Takayoshi, et al.
Publicado: (2022)

Serum high-mobility group box 1 protein level correlates with the lowest SaO(2) in patients with sleep apnea: a preliminary study
por: Min, Hyun Jin, et al.
Publicado: (2021)

Association between high mobility group box-1 protein expression and cell death in acute pancreatitis
por: Gao, Enjun, et al.
Publicado: (2017)

Publisher Correction: Association between high-mobility group box 1 levels and febrile seizures in children: a systematic review and meta-analysis
por: Li, Shangbin, et al.
Publicado: (2023)

Prognostic role of serum high mobility group box 1 concentration in cardiac surgery
por: Kim, Namo, et al.
Publicado: (2020)

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis
por: Zhang, Qiang-Bo, et al.
Publicado: (2016)

Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population
por: Biscetti, Federico, et al.
Publicado: (2021)

Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease
por: YAO, HENG-CHEN, et al.
Publicado: (2013)

Early antagonism of cerebral high mobility group box-1 protein is benefit for sepsis induced brain injury
por: Ren, Chao, et al.
Publicado: (2017)

Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia
por: Lu, Huasong, et al.
Publicado: (2019)

High-Mobility Group Box-1 Protein Serum Levels Do Not Reflect Monocytic Function in Patients with Sepsis-Induced Immunosuppression
por: Unterwalder, Nadine, et al.
Publicado: (2010)

Serum high mobility group box protein 1 (HMGB1) levels reflect clinical features of childhood hemophagocytic lymphohistiocytosis
por: Tsujimoto, Hiroshi, et al.
Publicado: (2019)

Correction to: Association between carotid plaque vulnerability and high mobility group box‑1 serum levels in a diabetic population
por: Biscetti, Federico, et al.
Publicado: (2021)

Evaluation of serum C-reactive protein and high mobility group box 1 concentrations in 22 dogs with acute pancreatitis: a pilot study
por: Kim, Hakhyun, et al.
Publicado: (2019)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications
por: Wu, Han, et al.
Publicado: (2016)

High-mobility group box 1 released from astrocytes promotes the proliferation of cultured neural stem/progenitor cells
por: LI, MAN, et al.
Publicado: (2014)

High mobility group box-1 levels in schizophrenia: Potential biomarker of remission phase
por: Yilmaz, Nuryil, et al.
Publicado: (2021)

Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes
por: Yoo, Hongseok, et al.
Publicado: (2021)

Role of high mobility group box-1 and protection of growth hormone and somatostatin in severe acute pancreatitis
por: Wang, Y.F., et al.
Publicado: (2014)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis
por: Chen, Linyan, et al.
Publicado: (2021)

High-Mobility Group Box-1 Induces Proinflammatory Cytokines Production of Kupffer Cells through TLRs-Dependent Signaling Pathway after Burn Injury
por: Chen, Xu-Lin, et al.
Publicado: (2012)

Serum high-mobility group box-1 protein as a specific marker of severe abdominal injury
por: Sakamoto, Y, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2cu4s3i1mk8vjv5rdl5r0l7l3r